Cita APA

Öhlund, P., García-Arriaza, J., Zusinaite, E., Szurgot, I., Männik, A., Kraus, A., . . . Ljungberg, K. (2018). DNA-launched RNA replicon vaccines induce potent anti-Ebolavirus immune responses that can be further improved by a recombinant MVA boost.

Citación estilo Chicago

Öhlund, Pontus, et al. DNA-launched RNA Replicon Vaccines Induce Potent Anti-Ebolavirus Immune Responses That Can Be Further Improved By a Recombinant MVA Boost. 2018.

Cita MLA

Öhlund, Pontus, et al. DNA-launched RNA Replicon Vaccines Induce Potent Anti-Ebolavirus Immune Responses That Can Be Further Improved By a Recombinant MVA Boost. 2018.